{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:09:08Z","timestamp":1788469748401,"version":"build-2803163510"},"reference-count":34,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy of Craiova, Romania"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Glaucoma is the primary cause of irreversible blindness worldwide, with enormous impact on quality of life and activities of daily living. Since one pathogenic mechanism of glaucoma is mitochondrial dysfunction at the retinal ganglion cell level, niacin has been proposed as an adjuvant treatment, with encouraging results. The objective of this prospective, non-randomized, single-arm clinical trial was to investigate the effect of oral supplementation with niacin on the quality of life of a cohort of glaucoma patients in Romania. Methods: Fifty-eight patients diagnosed with primary open angle glaucoma, under topical hypotensive treatment, were evaluated before and after a 6-month period of daily administration of 500 mg of oral niacinamide. Evaluation involved a complete ophthalmological exam and QoL quantification using the Glaucoma Quality of Life-15 (GQL-15) Questionnaire. Results: We found strong evidence that niacin supplementation for 6 months led to a statistically significant improvement in QoL scores among glaucoma patients (mean difference = \u22122.10, 95% CI: [\u22122.89, \u22121.32], p &lt; 0.0001), including central and near vision (mean difference = \u22122.16, 95% CI: [\u22123.91, \u22120.4], p = 0.017), peripheral vision (mean difference = \u22122.66, 95% CI: [\u22120.23, \u22120.08], p &lt; 0.001), and the glare and dark adaptation (mean difference = \u22125.24, 95% CI: [\u22120.33, \u22120.14], p &lt; 0.001). In addition, B3 treatment resulted in a significant reduction in intraocular pressure in both eyes over 6 months (mean difference = 0.53, 95% CI: [0.21, 0.86] in the left eye and mean difference = 0.36, 95% CI: [0.04, 0.68] in the right eye), indicating potential clinical benefits. Conclusions: The observed GQL-15 score reductions suggest that B3 may be of benefit in glaucoma management. Further research with larger sample sizes and placebo-controlled designs is needed to confirm B3 potential impact on disease progression and quality of life. Trial Registration at clinicaltrials.gov: NCT07007260.<\/jats:p>","DOI":"10.3390\/nu17172775","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:49:34Z","timestamp":1756309774000},"page":"2775","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Changes in Quality of Life Among Glaucoma Patients Following Six Months of Niacinamide Supplementation"],"prefix":"10.3390","volume":"17","author":[{"given":"Constantin Alin","family":"Nicola","sequence":"first","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-8809","authenticated-orcid":false,"given":"Maria Cristina","family":"Marinescu","sequence":"additional","affiliation":[{"name":"Discipline of Medical Physiology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Firan","sequence":"additional","affiliation":[{"name":"Barnsley Hospital, Barnsley Hospital NHS Foundation Trust, Barnsley S75 2EP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgica","family":"Tartea","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela Simona","family":"Naidin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Marketing and Management, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu Constantin","family":"Ciuluvica","sequence":"additional","affiliation":[{"name":"Discipline of Anatomy, Faculty of Dentistry, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Daniela","family":"Dimulescu","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta Mirela","family":"Voicu","sequence":"additional","affiliation":[{"name":"Discipline of Clinical Pharmacology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Marinela","family":"Mihailescu","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea-Daniela","family":"Meca","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacology, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8089-1787","authenticated-orcid":false,"given":"Maria","family":"Bogdan","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacology, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1374-276X","authenticated-orcid":false,"given":"Adina","family":"Turcu-Stiolica","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Marketing and Management, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Potop, V., Dragosloveanu, C.D.M., Cioc\u00e2lteu, A.M., Burcel, M.G., Marinescu, M.C., and D\u0103sc\u0103lescu, D.M.C. (2024). The Mirror Theory: Parallels between Open Angle and Angle Closure Glaucoma. Life, 14.","DOI":"10.3390\/life14091154"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040: A Systematic Review and Meta-Analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Coviltir, V., Burcel, M.G., Balt\u0103, G., and Marinescu, M.C. (2024). Interplay Between Ocular Ischemia and Glaucoma: An Update. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212400"},{"key":"ref_4","unstructured":"Teoli, D., and Bhardwaj, A. (2023). Quality of Life. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5005\/jp-journals-10078-1242","article-title":"Evaluation of Vision-Related Quality of Life in Patients with Glaucoma: A Hospital-Based Study","volume":"13","author":"Dhawan","year":"2019","journal-title":"J. Curr. Glaucoma Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamaophthalmol.2021.0146","article-title":"A Global Assessment of Eye Health and Quality of Life: A Systematic Review of Systematic Reviews","volume":"139","author":"Assi","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e004632","DOI":"10.1136\/bmjopen-2013-004632","article-title":"Is Glaucoma Comprehension Associated with Psychological Disturbance and Vision-Related Quality of Life for Patients with Glaucoma? A Cross-Sectional Study","volume":"4","author":"Kong","year":"2014","journal-title":"BMJ Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.5114\/aoms\/172929","article-title":"The National, Regional, and Global Impact of Glaucoma as Reported in the 2019 Global Burden of Disease Study","volume":"19","author":"Wu","year":"2023","journal-title":"Arch. Med. Sci. AMS"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Majern\u00edkov\u00e1, \u013d., Hud\u00e1kov\u00e1, A., Obro\u010dn\u00edkov\u00e1, A., Hal\u00e1sz, B.G., and Ka\u0161\u010d\u00e1kov\u00e1, M. (2021). Quality of Life of Patients with Glaucoma in Slovakia. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18020485"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/cam.3.1.7483","article-title":"NAD and Axon Degeneration: From the Wlds Gene to Neurochemistry","volume":"3","author":"Wang","year":"2009","journal-title":"Cell Adhes. Migr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/1028415X.2019.1637504","article-title":"Implications of NAD Metabolism in Pathophysiology and Therapeutics for Neurodegenerative Diseases","volume":"24","author":"Hikosaka","year":"2021","journal-title":"Nutr. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s40478-024-01850-8","article-title":"Oral Nicotinamide Provides Robust, Dose-Dependent Structural and Metabolic Neuroprotection of Retinal Ganglion Cells in Experimental Glaucoma","volume":"12","author":"Cimaglia","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Nicola, C.A., Marinescu, M.C., Firan, A.M., Naidin, M.S., Ciuluvica, R.C., Rosu, M.M., Meca, A.-D., Bogdan, M., and Turcu-Stiolica, A. (2024). Systematic Review and Meta-Analysis on the Association Between Daily Niacin Intake and Glaucoma. Nutrients, 16.","DOI":"10.3390\/nu16213604"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/IJG.0000000000000767","article-title":"Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma","volume":"26","author":"Williams","year":"2017","journal-title":"J. Glaucoma"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/IJG.0b013e3181752c83","article-title":"Assessing Quality of Life in Patients with Glaucoma Using the Glaucoma Quality of Life-15 (GQL-15) Questionnaire","volume":"18","author":"Goldberg","year":"2009","journal-title":"J. Glaucoma"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00061198-200304000-00009","article-title":"Quality of Life in Glaucoma and Its Relationship with Visual Function","volume":"12","author":"Nelson","year":"2003","journal-title":"J. Glaucoma"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/j.jval.2023.03.1817","article-title":"PCR37 Translation and Cultural Adaptation of the Glaucoma Quality of Life-15 Questionnaire to the Romanian Population","volume":"26","author":"Subtirelu","year":"2023","journal-title":"Value Health"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jfo.2022.06.017","article-title":"Cross-Cultural Adaptation and Validation of the Moroccan Version of the Glaucoma Quality of Life-15 (GQL-15) Questionnaire in Patients with Glaucoma","volume":"46","author":"Maiouak","year":"2023","journal-title":"J. Fr. d\u2019Ophtalmol."},{"key":"ref_19","first-page":"1674","article-title":"Validation of the Glaucoma Quality of Life-15 Questionnaire in Serbian Language","volume":"11","author":"Sencanic","year":"2018","journal-title":"Int. J. Ophthalmol."},{"key":"ref_20","first-page":"330","article-title":"Validation and Update of the Glaucoma Quality of Life (GQL)-15 Questionnaire for Spanish-Speaking Individuals","volume":"100","author":"Salamanca","year":"2025","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1167\/iovs.11-8538","article-title":"Do Patients with Glaucoma Have Difficulty Recognizing Faces?","volume":"53","author":"Glen","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4103\/tjo.TJO-D-24-00042","article-title":"Central Visual Field in Glaucoma: An Updated Review","volume":"14","author":"Du","year":"2024","journal-title":"Taiwan J. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MAJ.0000000000000319","article-title":"What Do Patients With Glaucoma See? Visual Symptoms Reported by Patients With Glaucoma","volume":"348","author":"Hu","year":"2014","journal-title":"Am. J. Med. Sci."},{"key":"ref_24","first-page":"11","article-title":"Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial","volume":"140","author":"John","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Bierings, R.A.J., Kuiper, M., van Berkel, C.M., Overkempe, T., and Jansonius, N.M. (2018). Foveal Light and Dark Adaptation in Patients with Glaucoma and Healthy Subjects: A Case-Control Study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193663"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/s41433-020-01164-8","article-title":"Glaucoma and Glare","volume":"35","author":"Hamedani","year":"2020","journal-title":"Eye"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41433-019-0679-5","article-title":"How Do Different Lighting Conditions Affect the Vision and Quality of Life of People with Glaucoma? A Systematic Review","volume":"34","author":"Enoch","year":"2020","journal-title":"Eye"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Babighian, S., Gattazzo, I., Zanella, M.S., Galan, A., D\u2019Esposito, F., Musa, M., Gagliano, C., Lapenna, L., and Zeppieri, M. (2024). Nicotinamide: Bright Potential in Glaucoma Management. Biomedicines, 12.","DOI":"10.3390\/biomedicines12081655"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1477-7525-11-188","article-title":"Linguistic and Psychometric Validation of the Chinese Version of the Glaucoma Quality of Life-15 (GQL-15-CHI): A Cross-Sectional Study","volume":"11","author":"Zhou","year":"2013","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.65.8.1","article-title":"Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition","volume":"65","author":"Zhang","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/tvst.13.3.24","article-title":"The Role and Mechanism of Nicotinamide Riboside in Oxidative Damage and a Fibrosis Model of Trabecular Meshwork Cells","volume":"13","author":"Zeng","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"101193","DOI":"10.1016\/j.mam.2023.101193","article-title":"Neuroprotection in Glaucoma: Mechanisms beyond Intraocular Pressure Lowering","volume":"92","author":"Tribble","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.4103\/1673-5374.373667","article-title":"The Pathology behind Glaucoma: What We Already Know Using Omics Technologies","volume":"18","author":"May","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/IJG.0000000000001889","article-title":"Educational Club of Ocular Surface and Glaucoma (ECOS-G) Members A Scoping Review of Quality of Life Questionnaires in Glaucoma Patients","volume":"30","author":"Gazzard","year":"2021","journal-title":"J. Glaucoma"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/17\/2775\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:33:46Z","timestamp":1760034826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/17\/2775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":34,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["nu17172775"],"URL":"https:\/\/doi.org\/10.3390\/nu17172775","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}